Home/Pipeline/Oncology Mutation Test Kits

Oncology Mutation Test Kits

Hematopoietic Disorders (MPN, AML, Lymphoma)

CommercialActive

Key Facts

Indication
Hematopoietic Disorders (MPN, AML, Lymphoma)
Phase
Commercial
Status
Active
Company

About TrimGen

TrimGen is a U.S.-based developer and provider of molecular diagnostic products focused on genetic mutation analysis. The company's proprietary Shifted Termination Assay (STA) technology enables rapid, sensitive, and cost-effective detection of key mutations in hematopoietic cancers and for pharmacogenetic applications. Its product portfolio targets clinical research and early disease detection, offering an alternative to more expensive and time-consuming methods like NGS and Sanger sequencing. As a private company, TrimGen serves a global customer base of biomedical laboratories.

View full company profile

Therapeutic Areas